top of page

Our special assays

MSD-web.png

 

anti-drug antibody (ADA) assay development

​

  • ADA tests play a pivotal role in drug development. These tests detect antibodies created in response to therapeutic biological drugs. The detection and characterization of anti-drug antibodies (ADA) are essential due to their possible profound effect on drug efficacy, safety, and patient well-being

  • Who is required to perform ADA testing?
    Regulatory agencies, including the FDA and EMA, mandate ADA testing for any company that develops biological products, such as protein / peptide-based drugs, therapeutic antibodies, vaccines, and gene therapies, etc.

6.png

 

anti-drug antibody (ADA) assay development

  • Quantitative multiplex proteomic analysis on small volume of samples, including bodily fluids.
     

  • Semi-quantitative analysis of single cell proteomics.
     

  • No need for separate bioinformatic analysis thanks to IsoSpeak®, an analytic program that can translate raw data into cell profiles and population shifts.
     

  • Several available panels with over 15 analytes.

Mitochondrial Assays
 

  • Isolation of mitochondria from cell culture.

​

  • Replacement of indigenous mitochondria with donor mitochondria.

​

  • ROS quantification, TMRM, heteroplasmy tests and more.

Multiple Tissue Arrays
 

  • High throughput – up to hundreds of samples on the same slide.

​

  • Flexible design.

​

  • IHC scoring based on staining intensity and cell proportion.

Assay development 

​

  • Establishment of optimal conditions for IHC and ISH.

4.png

Antibodies

​

  • Antibody profiling using IHC. 

​

  • Novel screening methods for production of monoclonal antibodies.

​

  • ELISA of all types.
     

  • ADA - Anti Drug Antibodies.

5.png

MS\MS​
 

  • GLP compliant method development and validation.
     

  • Detection and quantification of small molecules, peptides, RNA and DNA, proteins and antibodies in complex biological matrixes – plasma, serum, tissue, urine, saliva, CSF and more.
     

  • Toxicity, Pharmacokinetics and Pharmacodynamics.
     

  • Drug formulation and stability.

Sphero.png

3D tumor cells - Spheroids​
 

  • A method for replicating the tumor spatial organization, with an outer layer of highly proliferating cells, middle region comprising senescent cells and a core containing necrotic dead cells.
     

  • Co-culturing of several types of cells from the tumor microenvironment for enhanced complexity.
     

  • Penetration research into tumor cells by mirroring natural gradient of nutrients and environmental conditions.
     

  • Complex gene expression which more closely resembles that of a tumor tissue in vivo. 

bottom of page